Dapagliflozin structure activity relationship sar

中国科学院上海有机化学研究所机构知识库(SIOC OpenIR): Log In

dapagliflozin structure activity relationship sar

class of inhibitors and presented a structure–activity relationship (SAR) overview. inhibitors published thus far are structurally related to dapagliflozin. 1 discussed above, the structure-activity relationship (SAR) of 1 was explored, with . SGLT2 inhibitors was the discovery of dapagliflozin (Fig. 5). [15, 34]. KEYWORDS: dapagliflozin; diabetes; glucosuria; insulin resistance; phlorizin; .. agents in db/db mice: synthesis and structure-activity relationship studies.

The new pyrazolopyridones displayed comparable activities to the antitumor compound etoposide. The inhibitory effect of compounds 17, 18, 27 and 32 against topoisomerase II-mediated cleavage activities was measured finding good correlation with the results obtained from MTS assay. Single tumor cells circulating in the blood stream can be considered a major step in depicting dissemination of primary tumors, an event of clinical relevance for prognosis, staging or therapy monitoring of cancer.

The third leading cause of cancer death in men is colorectal cancer and the hematogenous spreading of primary tumor cells is one of the main events in metastasis of this type of cancer. Hidden in the myriad of circulating blood cells, tumor cells need both a sensitive and affordable detection technique. In addition, we found distinct accumulation of porphyrin depending on cancer type cutaneous melanoma versus colorectal cancer.

These data lead to the possibility of identifying circulating cells based on preferential accumulation of this new porphyrin in circulating tumor cells because, even accumulated in low percentage of cells the registered intensity of fluorescence was high.

Selecting the genetic markers for circulating tumor cells is an option, but high costs and high level of know-how can be somewhat a hurdle for a rapid evaluation. Thus our approach with a new porphyrin can be developed in an accurate and innovative fast tracking method for circulating cancer cells, at least in colorectal cancer patients.

Isothioureas are a class of amphiphilic compounds carrying a highly basic isothiourea group of pKa ranging between 10 and Hence, they exist in protonated cation form at physiological pH, a characteristic is of key importance for their pharmacological activity. Recently, we have found that a number of S-pentabromobenzylisothiourea derivatives show substantial cytotoxicity toward a variety of human glioblastoma, leukemia, and adenocarcinoma cell lines.

Whereas there is a growing body of data on aliphatic and alkylaromatic isothioureas, little attention was given to this day to heterocyclic isotiourea derivatives.

Here we report on the synthesis and pharmacological in vitro properties of 10 novel S- benzimidazolylmethyl - and S- 5,6-dichlorobenzimidazolylmethyl isothiourea derivatives. The compounds were obtained by the condensation of the respective 2-chloromethyl benzimidazoles with various substituted N N' -thioureas. Besides the essential physicochemical characteristics H-NMR, UV, elemental analysis of the new compounds, their log P values, which are of key importance for in vivo drug distribution and interactions, were determined.

  • Log In to the Repository
  • Discovery and development of gliflozins

Pharmacological anticancer activity of the compounds was evaluated based on their ability to induce apoptosis in exponentially growing cultures of the human acute myelogenous leukemia cell line KG-1; the apoptosis was assessed with a variety of flow cytometric methods.

We tested the antiproliferative activity and mechanism of the action of several novel aminoacridine derivatives. Six different cancer cell lines were used to evaluate the potential cytotoxic effect of eleven aminoacridine-based molecules.

A standard MTT assay was used for cell bioavailability analysis.

dapagliflozin structure activity relationship sar

Additionally, the potential cytotoxic effect of the tested compounds on non-cancer cells was investigated in rat skeletal muscle myotubes L6 and in bovine aortic smooth muscle cells. In order to investigate whether the DNA binding activity of tested compounds correlated with their cytotoxic effect, circular dichroism CD measurement and DNA T4 ligase assay were performed.

Finally, the potential mutagenic activity of the lead compound 5 was investigated.

Medicinal Chemistry (v.11, #4)

The cytotoxic effect of compound 5 in cancer cells was obtained in lower concentrations than the well-known: The lead compound binds to DNA, but in a different mode than the parent molecules. Additionally, compound 5 was not cytotoxic in the effective range of concentrations in non-cancer cells.

In identical concentrations, the parent compound 9-aminoacridine and amsacrine were extremely toxic for both types of these normal cells. Finally, based on CD measurement and T4 ligase assay, it was confirmed that 5 binds to DNA but in different from the parent compounds manner.

Important to mention, that compound 5 might have increased mutagenic activity which must be verified in vivo. Based on these in vitro results, we conclude that 5 is a more potent and more selective antiprolifirative compound than amsacrine. Compound 5 was also more effective in HepG2 and P cells. Thus, 5 is suitable for future in vivo biological evaluation and its structure might be used as a basis for developing novel anticancer drugs.

This study was conducted as a randomized, controlled clinical trial. In order to observe the hypoglycemic and lipid-lowering activity of LBP in patients with type 2 diabetes after dinner, various tests were conducted between control and LBP intervention groups in 3 months.

Although, the study had small sample size and short follow-up, significant findings were observed. It served a basis for the recognition of SGLT inhibitors with improved safety and tolerability profiles. For an example, the SGLT inhibitors are not associated with gastrointestinal adverse events and the bioavailability is much greater.

Some data supports the hypothesis that SGLT-2 inhibition may have direct renoprotective effects. This includes actions to attenuate tubular hypertrophy and hyperfiltration associated with diabetes and to reduce the tubular toxicity of glucose.

Initially, phlorizin was isolated for treatment of fever and infectious diseases, particularly malaria. According to Michael Nauck and his partners, studies were made in the s on phlorizin that showed that it could block sugar transport in the kidney, small intestine, and a few other tissues.

SAR of Acetylcholine (Explained with structures)

In later studies it was said[ by whom? Because of that, o-glucosides given orally have to be prodrug esters.

Structure Activity Relationship (SAR) Analysis - Creative Proteomics

These prodrugs go through changes in the body leading to carbon—carbon bond between the glucose and the aglycone moiety so c-glucoside are formed from the o-glucosides. C-glucosides have a different pharmacokinetic profile than o-glucosides e. The first discovered c-glucoside was the drug dapagliflozin. T is a methyl carbonate prodrug that is absorbed into the circulation when given orally, and is rapidly converted in the liver to the active metabolite TA.

Inhibition of SGLT-1 may also lead to the genetic disease glucose-galactose malabsorptionwhich is characterized by severe diarrhea.

It did not affect SGLT A study results on long-term use of ISIS in non-human primates observed more than fold increase in glucosuria without any associated hypoglycemia. The HbA1c was examined after SGLT-2 inhibitors were given alone as monotherapy and as an add-on therapy to the other diabetes medicines. The SGLT-2 inhibitors that were used were dapagliflozin and canagliflozin and others in the same drug class.

The meta-analysis was taken together from studies ranging from period of few weeks up to more than weeks. Two synergistic forces are involved in binding of inhibitors to SGLTs.

Different sugars on the aglycone will affect and change the orientation of it in the access vestibule because one of the forces involved in the binding is the binding of sugar to the glucose site.

The other force is the binding of the aglycone, which affects the binding affinity of the entire inhibitor. As an example we can take the change of o-glycosides to c-glycosides by creating a carbon—carbon bond between the glucose and the aglycone moiety. C-glucosides are more stable than o-glucosides which leads to modified half life and duration of action.

dapagliflozin structure activity relationship sar